KR
EN
MENU

Total Service for RNA

Research to Market

We Make Your Work Work

CURABLE

curable Inc. started as a genetic analysis and genetic disease diagnosis project in 2000 and is focusing on research using Korean epigenetic data based on a cohort selected as an academic service company of the Korea Centers for Disease Control and Prevention in 2016.
In 2021, we developed DDS technology using new microfluidic-based lipid nanoparticles (LNPs) to become a reliable partner for biopharmaceutical developers, and is set to launch in the fourth quarter of 2022 primarily by preparing RNA treatment and vaccine consignment production services.
We provide customization services from research to non-clinical and clinical trial samples at cGMP-certified facilities. In addition to consignment production, we will expand our business to consignment production that provides drug development and manufacturing services at once, and we will work with customers who need mass production of small molecule new drugs and medicines as well as RNA.

Research to Market

Our Offerings

Customized Manufacturing Services

RNA Synthesis Service

  • non-GMP grade research RNA (miRNA, siRNA, ASO, mRNA)
  • cGMP grade preclinical RNA: min. 10μmol
  • cGMP grade clinical RNA: min. 10μmol
* Sample yield may change according to list of analysis required
STEP 1
RNA Synthesis
STEP 2
Purification
STEP 3
Lyophilization
STEP 4
QC

Customized DDS Synthesis Service

  • Customer provided RNA + Custom DDS
    (LNP, Liposome, PLGA, GalNAc): max. 5g/batch (1000mL/min)
  • Custom RNA + Custom DDS: max. 5g/batch (1000mL/min)
    *Capacity based on LNP formulation
STEP 5
Encapsulation
STEP 6
Buffer Change & Concentration
STEP 7
QC

List of Instruments & Analytics

  • RNA Synthesis

    RNA Synthesis

    RNA Synthesizer(3)

    Purification

    FPLC (3)

    Lyophilization

    Lyophilizer

    Centrifugal Vaccum Concentrator

  • DDS Formulation

    Formulation

    Microfluidics (4)

    TFF system

    TFF (3)

  • Quality Control

    Osmometry

    Osmometer

    Moisture Analysis

    Moisture Titrator

    RNA Identification

    UV-Vis Spectrometer

    LC-MS

    Encapsulation Efficiency

    Microplate reader

    RNA Purity

    UHPLC

    HPLC

    Residual Measure

    GC-FID

    LNP Physical Property

    Zeta potential & Particle Size Analyzer

  • Analytics & Quality Control

    Appearance

    Particle size

    Zeta potential

    PDI (Polydispersity Index)

    Content of RNA

    Encapsulation Efficiency

    Residual solvents

    Osmotic pressure

    Endotoxin

    Bioburden

    pH

    Identification (MS analysis)

    Purity

    Melting temperature

    Elemental Impurities

    Water content

    Sodium content

Business

CDMO Business

Provides “Contract Manufacturing” Service for pharmaceuticals
Provides “Process Optimization” Service for pharmaceuticals

Co-Development

Cooperative relationship (revenue distribution) between Customer, curable (CDMO), CRO for co-development of pipelines

We Make Your Work Work

Our Abilities

RNA based therapeutics & vaccines contract manufacturing services applying DDS manufacture technology and nano particle mass produce technology.
  • Microfluidics platform solved problems in nano particle mass production.
  • New LNP manufacturing technology solved existing LNP patent problem.
  • CMC/RA Solution fullfill IND & NDA regulation requirements

Milestone

RESEARCH
PRECLINICAL
PHASE I
PHASE II
PHASE III
MARKET
Non-GMP
October 2022: RNA Synthesis / Custom DDS Synthesis Service
Non-GMP
October 2022: RNA Synthesis / Custom DDS Synthesis Service
GMP
Q1 2023: RNA Synthesis / Custom DDS Synthesis Service / Process Development / CMC & RA
GMP (Mass production)
Q4 2025: Oligonucleotide Synthesis / Custom DDS Synthesis Service
Microfluidics applied Service / Process Development / CMC & RA

Total Service for RNA

Contact Us

Headquarter (R&D center)

10F, 93 Dongtan-daero 23-gil, Hwaseong-si, Gyeonggi-do

Service Launching Date

October, 2022

Contact

+82-31-376-1671 +82-31-372-1680

Inquiry

Please feel free to contact us.
Once you submit inquiry, we will get back to you as soon as possible.
Advertisement or spam inquiries will be disposed without notifications.
Name
Company
Email
Phone
Content

© 2024 CURABLE INC.

10F 93, Dongtan-daero 23-gil, Hwaseong-si, Gyeonggi-do, Republic of Korea

Tel. +82-31-376-1671|Email. [email protected]